Virus replication in engineered human cells that do not respond to interferons.
The V protein of the paramyxovirus simian virus 5 blocks interferon (IFN) signaling by targeting STAT1 for proteasome-mediated degradation. Here we report on the isolation of human cell lines that express the V protein and can no longer respond to IFN. A variety of viruses, particularly slow-growing wild-type viruses and vaccine candidate viruses (which are attenuated due to mutations that affect virus replication, virus spread, or ability to circumvent the IFN response), form bigger plaques and grow to titers that are increased as much as 10- to 4,000-fold in these IFN-nonresponsive cells. We discuss the practical applications of using such cells in vaccine development and manufacture, virus diagnostics and isolation of newly emerging viruses, and studies on host cell tropism and pathogenesis.
Young
D F
DF
School of Biology, University of St. Andrews, Fife KY16 9TS, United Kingdom.
Andrejeva
L
L
Livingstone
A
A
Goodbourn
S
S
Lamb
R A
RA
Collins
P L
PL
Elliott
R M
RM
Randall
R E
RE
D000818:Animals; D002460:Cell Line; D002522:Chlorocebus aethiops; D006801:Humans; D007372:Interferons / Q000494:pharmacology*; D014162:Transfection; D014614:Vaccines, Synthetic / Q000276:immunology; D014709:Vero Cells; D014765:Viral Vaccines / Q000276:immunology; D014779:Virus Replication; D014780:Viruses / Q000187:drug effects*
D014614:Vaccines, Synthetic; D014765:Viral Vaccines; D007372:Interferons